Lina Han

3.9k total citations
56 papers, 743 citations indexed

About

Lina Han is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Lina Han has authored 56 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Hematology and 11 papers in Oncology. Recurrent topics in Lina Han's work include Acute Myeloid Leukemia Research (22 papers), Protein Degradation and Inhibitors (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Lina Han is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Protein Degradation and Inhibitors (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Lina Han collaborates with scholars based in United States, China and Japan. Lina Han's co-authors include Edo Vellenga, Jan Jacob Schuringa, Marina Konopleva, Sandra Olthof, Aleksandra Rizo, Gerald de Haan, Yeong Shik Kim, Youmie Park, Michael Andreeff and Seonho Cho and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lina Han

54 papers receiving 738 citations

Peers

Countries citing papers authored by Lina Han

Since Specialization

Citations

This map shows the geographic impact of Lina Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Han more than expected).

Fields of papers citing papers by Lina Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lina Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Han. The network helps show where Lina Han may publish in the future.

Co-authorship network of co-authors of Lina Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lina Han. A scholar is included among the top collaborators of Lina Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lina Han. Lina Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment 2025 ·European Journal Of Haematology ·Ruifang Zheng, Jeffrey Gagan, Giovanni A. Botten, (unknown), Olga K. Weinberg, Mingyi Chen, (unknown), Jesse Jaso, (unknown), Hung S. Luu, Lina Han, (unknown), Kathryn E. Dickerson, Samuel John, Yazan F. Madanat, Stephen W. Chung, Robert J. Collins, (unknown), Franklin Fuda, Weina Chen	2
2	Advanced Technologies in Healthcare 2023 ·Shuli Guo, Lina Han, (unknown)	3
3	Effect of exogenous hydrogen sulfide in the nucleus tractus solitarius on gastric motility in rats 2023 ·World Journal of Gastroenterology ·(unknown), Chenyu Li, Yuan Shi, Jinjin Li, Yiya Wang, Lina Han, (unknown), Yafei Zhang	0
4	Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1α In Vitro 2022 ·Frontiers in Pharmacology ·(unknown), Lina Han, (unknown), Chao Li, (unknown), (unknown)	9
5	Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation 2020 ·Cellular Oncology ·Jun Ma, Lina Han, Jianrui Song, Xiaoming Bai, (unknown), Lifeng Meng, Jian Li, Wen Zhou, (unknown), (unknown), (unknown), (unknown), (unknown)	22
6	Mitochondrial Oxphos As Survival Mechanism of Minimal Residual AML Cells after Induction Chemotherapy : Survival Benefit By Complex I Inhibition with Iacs-010759 2019 ·Blood ·Lina Han, Antonio Cavazos, Natalia Baran, Qi Zhang, Vinitha M. Kuruvilla, Jason Gay, Ningping Feng, Venkata Lokesh Battula, Hagop M. Kantarjian, Naval Daver, Joseph R. Marszalek, Michael Andreeff, Marina Konopleva	15
7	Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Brittany Knick Ragon, Olatoyosi Odenike, Maria R. Baer, Wendy Stock, Gautam Borthakur, Keyur P. Patel, Lina Han, Helen Chen, Helen Ma, Loren Joseph, Yang Zhao, Keith Baggerly, Marina Konopleva, Nitin Jain	51
8	Targeting BCL-XL By Protac DT2216 Effectively Eliminates Leukemia Cells in T-ALL Pre-Clinical Models 2019 ·Blood ·Qi Zhang, Sajid Khan, Xuan Zhang, Vinitha M. Kuruvilla, (unknown), (unknown), Natalia Baran, Tianyu Cai, Lina Han, Adolfo A. Ferrando, Yong‐Mi Kim, Guangrong Zheng, Daohong Zhou, Marina Konopleva	8
9	Initial report of a phase I study of LY2510924 with idarubicin and cytarabine (IA) in relapsed/refractory (R/R) AML. 2018 ·Journal of Clinical Oncology ·Prajwal Boddu, Gautam Borthakur, Kiran Naqvi, William G. Wierda, Prithviraj Bose, Elias Jabbour, Zeev Estrov, Jan A. Burger, Yesid Alvarado, (unknown), Ami Patel, Antonio Cavazos, Lina Han, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva	1
10	BCL-2 Antagonist ABT-199 Combined with Complex I Inhibitor IACS-010759 Blocks Mitochondrial Respiration and Facilitates Anti-Leukemia Efficacy in Pre-Clinical AML Models 2017 ·Blood ·Qi Zhang, Lina Han, Tianyu Cai, Vinitha M. Kuruvilla, Antonio Cavazos, Helen Ma, Venkata Lokesh Battula, Natalia Baran, Karine G. Harutyunyan, Michael Andreeff, Yoko Tabe, Joseph R. Marszalek, Marina Konopleva	2
11	MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Qi Zhang, Lina Han, Rongqing Pan, Ce Shi, Jeremy Ryan, Man Chun John, Steven M. Kurtz, Hong Mu, Vivian Ruvolo, Helen Ma, Yingchang Mi, Jeffrey Tyner, (unknown), R. Eric Davis, Michael Andreeff, Marina Konopleva	0
12	Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML 2016 ·Blood ·Qí Zhāng, Lina Han, Ce Shi, Rongqing Pan, Man Chun John, Jeremy Ryan, Stephen E. Kurtz, Hong Mu, Vivian Ruvolo, Helen Ma, Michael Andreeff, Yingchang Mi, Jeffrey Tyner, Joel Johansson, Anthony Letai, R. Eric Davis, Marina Konopleva	5
13	The induction of apoptosis by a newly synthesized diosgenyl saponin through the suppression of estrogen receptor-α in MCF-7 human breast cancer cells 2013 ·Archives of Pharmacal Research ·Jaemoo Chun, Lina Han, (unknown), Bo Wang, (unknown), Yeong Shik Kim	12
14	Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide 2013 ·Leukemia & lymphoma ·Zhuo Zhang, Yan Chen, (unknown), (unknown), Qian Zhou, Ce Shi, Lina Han, (unknown), Jin Zhou	6
15	BCL-2-Selective BH3 Mimetic ABT-199 Is a Potent Agent For Acute Myeloid Leukemia 2013 ·Blood ·Rongqing Pan, LaKeisha Debose, Juliana M. Benito, Leonard S. Golfman, Patrick A. Zweidler‐McKay, Lina Han, Karine G. Harutyunyan, Hong Mu, Vivian Ruvolo, Eugene Park, Markus Müschen, Joel Johansson, Gautam Borthakur, Hagop M. Kantarjian, Peter P. Ruvolo, Michael Andreeff, Marina Konopleva	4
16	Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia 2012 ·Cancer ·Yingmei Zhang, Zhuo Zhang, Jinmei Li, Limin Li, Xueying Han, Lina Han, (unknown), Shuye Wang, Yanhong Zhao, Xiaoxia Li, Ying Zhang, Shengjin Fan, (unknown), Yinghua Li, Yanhua Su, Hui Zhao, Xin Zhang, Jin Zhou	32
17	Artemisia capillaris Extracts as a Green Factory for the Synthesis of Silver Nanoparticles with Antibacterial Activities 2012 ·Journal of Nanoscience and Nanotechnology ·Youmie Park, (unknown), Lina Han, Hyun‐Seok Kim, Yong‐Jae Kim, Jae Sue Choi, Chong‐Kook Kim, Yeong Shik Kim, Seonho Cho	37
18	Synthesis of novel diosgenyl saponin analogues and apoptosis-inducing activity on A549 human lung adenocarcinoma 2012 ·Organic & Biomolecular Chemistry ·Bo Wang, Jaemoo Chun, Yang Liu, Lina Han, (unknown), (unknown), (unknown), (unknown)	19
19	Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases 2010 ·Annals of Hematology ·Lina Han, Jan Jacob Schuringa, André B. Mulder, Edo Vellenga	15
20	KRASG12V Enhances Proliferation and Initiates Myelomonocytic Differentiation in Human Stem/Progenitor Cells via Intrinsic and Extrinsic Pathways 2010 ·Journal of Biological Chemistry ·Szabolcs Fátrai, Djoke van Gosliga, Lina Han, Simon Daenen, Edo Vellenga, Jan Jacob Schuringa	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact